Alqahtani, S.; Alqahtani, M.; Amer, K.; Ur Rahman, F.; AlMasoudi, R.; Al-Otaibi, S.; Alahmary, B.; Asiri, O.; Alshamrani, A.; Alshehri, R.;
et al. Favipiravir for COVID-19 Pneumonia: Effectiveness, Safety, and Clinical Outcomes: A Retrospective Single-Center Experience. COVID 2024, 4, 1971-1984.
https://doi.org/10.3390/covid4120139
AMA Style
Alqahtani S, Alqahtani M, Amer K, Ur Rahman F, AlMasoudi R, Al-Otaibi S, Alahmary B, Asiri O, Alshamrani A, Alshehri R,
et al. Favipiravir for COVID-19 Pneumonia: Effectiveness, Safety, and Clinical Outcomes: A Retrospective Single-Center Experience. COVID. 2024; 4(12):1971-1984.
https://doi.org/10.3390/covid4120139
Chicago/Turabian Style
Alqahtani, Saad, Mushary Alqahtani, Khaled Amer, Fasih Ur Rahman, Razan AlMasoudi, Sahar Al-Otaibi, Batool Alahmary, Osama Asiri, Abdulaziz Alshamrani, Razan Alshehri,
and et al. 2024. "Favipiravir for COVID-19 Pneumonia: Effectiveness, Safety, and Clinical Outcomes: A Retrospective Single-Center Experience" COVID 4, no. 12: 1971-1984.
https://doi.org/10.3390/covid4120139
APA Style
Alqahtani, S., Alqahtani, M., Amer, K., Ur Rahman, F., AlMasoudi, R., Al-Otaibi, S., Alahmary, B., Asiri, O., Alshamrani, A., Alshehri, R., Asiri, F., Alqahtani, M., Alshahrani, A., & Elsharif, Y.
(2024). Favipiravir for COVID-19 Pneumonia: Effectiveness, Safety, and Clinical Outcomes: A Retrospective Single-Center Experience. COVID, 4(12), 1971-1984.
https://doi.org/10.3390/covid4120139